Stock Updates

A look at a High Market Cap Stock: IDEXX Laboratories, Inc., IDXX

IDEXX Laboratories, Inc., IDXX is in the exchange NASDAQ and its industry is Diagnostic Substances in the sector of Healthcare. Based in USA, IDEXX Laboratories, Inc., IDXX  has a market cap of 10358.5. Since its IPO date on the 6/24/1991, IDEXX Laboratories, Inc., IDXX performance year to date is 58.15%. Today IDEXX Laboratories, Inc., IDXX has gained 1.95%, with a current price of 115.32.

Ownership of the company is 1.30% for insider ownership while institutional ownership is 94.90%. The management of the company have seen the company have a payout ratio of 0.00%. Return of assets are at 13.60%, with return on investment at 22.10%.

In terms of debt levels and profit levels, IDEXX Laboratories, Inc., IDXX is seeing a long-term debt/equity of *TBA. While Total debt/equity is *TBA. With a profit margin of 11.90%, this is combined with a gross margin of 55.00%, and operating margin of 18.70%. IDEXX Laboratories, Inc. ability to meet debt levels, with a current ratio of 1, while the quick ratio is 0.8.

For the last year IDEXX Laboratories, Inc., IDXX has seen a EPS growth of 14.40%. A performance for the year of 57.54%. The 52-week high is 0.23%, and the 52-week low is 81.66%. The average volume for IDEXX Laboratories, Inc., IDXX is 794600.

With a target price of 116.8, can IDEXX Laboratories, Inc., IDXX reach this target? Looking at the value indicators of IDEXX Laboratories, Inc., IDXX. IDEXX Laboratories, Inc. has a P/E of 52.2 and a forward P/E of 42.82. Perhaps the more useful indicator than P/E, is PEG which has a value of 3.64. IDEXX Laboratories, Inc. also has a P/S and a P/B of 6.13 and *TBA respectively. For P/cash, IDEXX Laboratories, Inc. has a value of 27.98, while it is 49.07 for P/free cash flow.

At the current price of 115.32, IDEXX Laboratories, Inc. has a dividend yield of *TBA. We see a return on equity of -392.60%.

Looking more long-term IDEXX Laboratories, Inc., is projected to get an EPS growth for the next five years of 14.35%. In the short-term an EPS growth of 14.06% in the next year is forecasted. This is after a EPS growth of 14.40% for this year and for the last five years a 11.60% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment